Skip to main content
Log in

Immunosuppressive Drugs and Corticosteroids in the Treatment of Rheumatoid Arthritis

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Rheumatoid arthritis is the most common form of severe inflammatory arthropathy affecting patients at a relatively early age. Although there are a number of drugs which significantly reduce pain and swelling, few alter the development of erosions and progression of joint destruction. A significant number of patients with rheumatoid arthritis develop this progressive disability and will require treatment with corticosteroids or immunosuppressive agents.

In this article the use of immunosuppressive drugs and corticosteroids in the treatment of aggressive rheumatoid arthritis is reviewed. Controlled clinical trials have shown that a number of these drugs can play a significant role in reducing pain and swelling and might possibly alter the disease course in rheumatoid arthritis. Side effects of these agents, including the potential for oncogenesis, still pose major problems in their long term use. The risks and benefits of immunosuppressive and corticosteroid drug therapy must be balanced in each patient to whom they are prescribed and reviewed at frequent intervals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Allison AC, Lee SW. Proinflammatory and catabolic effects of interleukin-1 and their antagonism by glucocorticoids. Variability in response to antirheumatic drugs. In Brooks PM & Day RD (Eds) Agents and Actions (Suppl.), in press, 1988

  • Amor B, Mery C. Chlorambucil in rheumatoid arthritis. Clinics in Rheumatic Diseases 6: 567–584, 1980

    Google Scholar 

  • Anderson PA, West SG, O’Dell JR, Via CS, Claypool RG, et al. Weekly pulse methotrexate in rheumatoid arthritis: clinical and immunological effects in a randomised double blind study. Annals of Internal Medicine 103: 489–496, 1985

    Google Scholar 

  • Anon. Cyclosporin in autoimmune disease. Lancet 1: 909–911, 1985

  • Aptekar RG, Atkinson JP, Decker JL, Wolff SM, Chu EW. Bladder toxicity with chronic oral cyclophosphamide therapy in non malignant disease. Arthritis and Rheumatism 16: 461–467, 1973

    PubMed  CAS  Google Scholar 

  • Austin HA, Klippel JM, Balow JE, Le Riche NGH, Steinberg AD, et al. Treatment of lupus nephritis: controlled trial of prednisone and cytotoxic drugs. New England Journal of Medicine 314: 614–619, 1986

    PubMed  Google Scholar 

  • Axelrod L. Glucocorticoids. In Kelly WN (Ed.) Textbook of rheumatology, pp. 815–832, Saunders, Philadelphia, 1985

    Google Scholar 

  • Baker GL, Kahl LE, Lee BC, Stolzer BL, Agarwal AK, et al. Malignancy following treatment with cyclophosphamide: long term case-control follow-up study. American Journal of Medicine 83: 1–9, 1987

    PubMed  CAS  Google Scholar 

  • Balin PL, Tindall JP, Roenigk HH, Hogan MD. Is methotrexate therapy for psoriasis carcinogenic? A modified retrospective and prospective analysis. Journal of the American Medical Association 232: 359–362, 1975

    Google Scholar 

  • Baltus JAM, Boersma JW, Hartman AP, Vandenbroucke JP. The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow up. Annals of the Rheumatic Diseases 43: 368–373, 1983

    Google Scholar 

  • Berg KJ, FørreØ, Bjerkhøel F, Amundsen E, Djøseland O, et al. Side effects of cyclosporin A treatment in patients with rheumatoid arthritis. Kidney International 29: 1180–1187, 1986

    PubMed  CAS  Google Scholar 

  • Bernstein CA, Freyberg RH. Rheumatoid patients after 5 or more years of corticosteroid treatment: a comparative analysis of 183 cases. Annals of Internal Medicine 54: 938–953, 1961

    Google Scholar 

  • Berry H, Liyanage SP, Durance RA, Barnes GC, Berger LA, et al. Azathioprine and penicillamine in the treatment of rheumatoid arthritis: a controlled trial. British Medical Journal 1: 1052–1054, 1976

    PubMed  CAS  Google Scholar 

  • Bird H. The role of steroids in the treatment of arthritis: conference report. Annals of the Rheumatic Diseases 44: 642–643, 1985

    Google Scholar 

  • Bitter T. Combined disease modifying chemotherapy for intractible rheumatoid arthritis. Clinics in Rheumatic Diseases 10: 417–428, 1984

    PubMed  CAS  Google Scholar 

  • Black RL, O’Brien W, Van Scott E, Averbach R, Eisen AZ, et al. Methotrexate therapy in psoriatic arthritis: double blind study on 21 patients. Journal of the American Medical Association 189: 743–747, 1964

    PubMed  CAS  Google Scholar 

  • Boardman PL, Hart FD. Clinical measurements of the anti-inflammatory effects of salicylates in rheumatoid arthritis. British Medical Journal 4: 264–268, 1967

    PubMed  CAS  Google Scholar 

  • Bontoux D, Kahan A, Brouilhet H, Amor B, Delbarre F. Effect and mode of action of chlorambucil in rheumatoid disease. Revue du Rhumatisme et des Maladies Ostéo-Articulaires 38: 759–764, 1971

    PubMed  CAS  Google Scholar 

  • Bookbinder SA, Espinoza LR, Fenske NA, Germaine BF, Vasey FB, et al. Methotrexate: its use in the rheumatic diseases. Clinical and Experimental Rheumatology 2: 185–193, 1984

    PubMed  CAS  Google Scholar 

  • Brooks PM, Kean W F, Buchanan WW. The clinical pharmacology of anti-inflammatory agents, pp. 123–134, Taylor and Francis, London, 1986

    Google Scholar 

  • Butler D, Tiliakos N. Low dose cytotoxic drug combination therapy in intractible rheumatoid arthritis. Arthritis and Rheumatism 28: S15, 1985

    Google Scholar 

  • Byron MA, Kirwan JR. Corticosteroids in rheumatoid arthritis: is a trial of their disease modifying potential feasible? Annals of the Rheumatic Diseases 46: 171–173, 1986

    Google Scholar 

  • Calabresi P, Parks RE. Chemotherapy of neoplastic diseases. In Gilman AG & Goodman LS (Eds) The pharmacological basis of therapeutics, pp. 1249–1313, MacMillan, New York, 1970

    Google Scholar 

  • Cannon GW, Jackson CG, Samuelson CO, Ward JR, Williams JM, et al. Chlorambucil therapy in rheumatoid arthritis: clinical experience in 28 patients and literature review. Seminars in Arthritis and Rheumatism 15: 106–118, 1985

    PubMed  CAS  Google Scholar 

  • Carson CW, Cannon GW, Egger MJ, Ward JR, Clegg DO, et al. Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate. Seminars in Arthritis and Reheumatism 16: 186–195, 1987

    CAS  Google Scholar 

  • Cayla J, Rondier J. The treatment of 67 cases of rheumatoid arthritis with chlorambucil drugs: with reference to 41 cases. Revue du Rhumatisme et des Maladies Ostéo-Articulaires 38: 771–774, 1971

    Google Scholar 

  • Chanbe S, Krug G, Murphy ML. Teratogenic effects of cyclophosphamide in rats. Cancer Chemotherapy and Pharmacology 51: 363–367, 1971

    Google Scholar 

  • Cobb S, Anderson F, Bauer W. Length of life and cause of death in rheumatoid arthritis. New England Journal of Medicine 249: 553–556, 1953

    PubMed  CAS  Google Scholar 

  • Cohen DJ, Loertscher R, Rubin MF, Tillney NL, Carpenter CB, et al. Cyclosporine: a new immunosuppressive agent for organ transplantation. Annals of Internal Medicine 101: 667–682, 1984

    PubMed  CAS  Google Scholar 

  • Conn HO, Blitzer BL. Non-association of adrenocorticosteroid therapy and peptic ulcer. New England Journal of Medicine 294: 471–479, 1976

    Google Scholar 

  • Cooperating Clinics Committee of the American Rheumatism Association. A controlled trial of cyclophosphamide in rheumatoid arthritis. New England Journal of Medicine 283: 884–889, 1970

    Google Scholar 

  • Cooperating Clinics Committee of the American Rheumatism Association. A controlled trial of high and low doses of cyclophosphamide in 82 patients with rheumatoid arthritis. Arthritis and Rheumatism 15: 434, 1972

    Google Scholar 

  • Csuka ME, Carrera GF, McCarty DJ. Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine and hydroxychloroquine. Journal of the American Medical Association 255: 2315–2319, 1986

    PubMed  CAS  Google Scholar 

  • Cupps TR, Fauci AS. The vasculitides, pp. 155–172, WB-Saunders Co., Philadelphia, 1981

    Google Scholar 

  • Currey HLF, Harris J, Mason M, Woodland J, Beveridge T, et al. Comparison of azathioprine, cyclophosphamide and gold in the treatment of rheumatoid arthritis. British Medical Journal 3: 763–766, 1974

    PubMed  CAS  Google Scholar 

  • Cushman P. Glucocorticoids and the gastrointestinal tract: current status. Gut 11: 534–539, 1970

    PubMed  Google Scholar 

  • Dalavanga YA, Detrick B, Hooks JJ, Dzosos AA, Moutsopoulos HM. Effect of cyclosporin A (Cy A) on the immunopathological lesion of the minor salivary glands from patients with Sjogren’s syndrome. Annals of the Rheumatic Diseases 46: 89–92, 1987

    PubMed  CAS  Google Scholar 

  • De Andrade JR, McCormick JN, Hill AGS. Small doses of prednisolone in the treatment of rheumatoid arthritis. Annals of the Rheumatic Diseases 24: 158–162, 1964

    Google Scholar 

  • De Fronzo RA, Braine H, Colvin M, Davis PJ. Water intoxication in man after cyclophosphamide therapy: time course and relation to drug activation. Annals of Internal Medicine 78: 861–869, 1973

    Google Scholar 

  • De Silva M, Hazleman BL. Long term azathioprine in rheumatoid arthritis: a double blind study. Annals of the Rheumatic Diseases 40: 560–563, 1981

    PubMed  Google Scholar 

  • Decker JL. Azathioprine and cyclophosphamide as slow acting drugs in rheumatoid arthritis. Journal of the American Medical Association 76: 74–78, 1983

    Google Scholar 

  • Deodhar SD, Dick WC, Hodgkinson R, Buchanan WW. Measurement of clinical response to anti-inflammatory drug therapy in rheumatoid arthritis. Quarterly Journal of Medicine 42: 387–401, 1973

    PubMed  CAS  Google Scholar 

  • Deshayes P, Renier JC, Bregeon C, Houdent G. Incidents et accidents des théraputiques à visée immunodépressive dans la polyarthrite rheumatoide. Revue du Rhumatisme et des Maladies Ostéo-Articulaires 38: 797–806, 1971

    PubMed  CAS  Google Scholar 

  • Diaz A, Gonzalez B, Cortez J, Mintz G. A prospective study of methotrexate (MTX) and D-penicillamine (D-P) in rheumatoid arthritis (RA). Clinical and Experimental Rheumatology 5(S-2): 1231987

    Google Scholar 

  • Dougados M, Amor B. Cyclosporin in rheumatoid arthritis. Arthritis and Rheumatism 28 (Suppl.): S36, 1985

    Google Scholar 

  • Dougados M, Amor B. Cyclosporin A in rheumatoid arthritis: preliminary results of an open trial. Arthritis and Rheumatism 30: 83–87, 1987

    PubMed  CAS  Google Scholar 

  • Dougados M, Awada H, Amor B. Cyclosporin in rheumatoid arthritis: a double blind placebo controlled trial in 52 patients. Clinical and Experimental Rheumatology 5 (Suppl. 2): 124, 1987

    Google Scholar 

  • Drosos AA, Skopoulis FN, Costopoulos JS, Papadimitriou CS, Moutsopoulos HM. Cyclosporin A (Cy A) in primary Sjogren’s syndrome: a double blind study. Annals of the Rheumatic Diseases 45: 732–735, 1986

    PubMed  CAS  Google Scholar 

  • Duggan CJ, Caterson RJ, Mahony JF, Boyce EF. Successful pregnancy in a renal transplant recipient taking cyclosporin A. Australian and New Zealand Journal of Medicine 16: 813–814, 1986

    PubMed  CAS  Google Scholar 

  • Dwosh IL, Stein HB, Urowitz MB, Smythe HA, Hunter T, et al. Azathioprine in early rheumatoid arthritis: comparison with gold and chloroquine. Arthritis and Rheumatism 20: 685–692, 1977

    PubMed  CAS  Google Scholar 

  • Edelman J, Russell AS, Biggs DF, Rothman RS, Coates J. Methotrexate levels, a guide to therapy? Clinical and Experimental Rheumatology 1: 153–156, 1983

    PubMed  CAS  Google Scholar 

  • Ejstrup L. Severe dermatomyositis treated with cyclosporin A. Annals of the Rheumatic Diseases 45: 612–613, 1986

    PubMed  CAS  Google Scholar 

  • Ellis CN, Gorsulowsky DC, Hamilton TA, Billings JR, Brown HD, et al. Cyclosporin improves psoriasis in a double blind study. Journal of the American Medical Association 256: 3110–3116, 1986

    PubMed  CAS  Google Scholar 

  • Empire Rheumatism Council. Multicentre controlled trial comparing cortisone acetate and acetylsalicylic acid in the long term treatment of rheumatoid arthritis. Annals of the Rheumatic Diseases 16: 277–289, 1957

    Google Scholar 

  • Fairchild WV, Spence CR, Solomon HD, Gangai MP, et al. The incidence of bladder cancer after cyclophosphamide therapy. Journal of Urology 122: 163–164, 1979

    PubMed  CAS  Google Scholar 

  • Fitzcharles MA, Halsey J, Currey HLF. Conversion from daily to alternate daily corticosteroids in rheumatoid arthritis. Annals of the Rheumatic Diseases 41: 66–68, 1982

    PubMed  CAS  Google Scholar 

  • Fitzgerald O, Hanly J, Molony J, Bresnihan B. Poor longterm results from low dose methotrexate in rheumatoid arthritis. Arthritis and Rheumatism 27: 599–600, 1984

    PubMed  CAS  Google Scholar 

  • Flower RJ, Blackwell GJ. Antiinflammatory steroids induce synthesis of a phospholipase-A2 inhibitor which prevents prostaglandin generation. Nature 278: 456–459, 1979

    PubMed  CAS  Google Scholar 

  • Førre O, Bjerghoel F, Salvesen CF, et al. An open, controlled, randomised comparison of cyclosporin and azathioprine in the treatment of rheumatoid arthritis: a preliminary report. Arthritis and Rheumatism 30: 88–92, 1987

    PubMed  Google Scholar 

  • Fosdick WM, Parsons JL, Hill DF. Long term cyclophosphamide therapy in rheumatoid arthritis. Arthritis and Rheumatism 11: 151–161, 1968

    PubMed  CAS  Google Scholar 

  • Fosdick WM, Parsons JL, Hill DF. Long term cyclophosphamide therapy in rheumatoid arthritis: a progress report, six years’ experience. Arthritis and Rheumatism 12: 663, 1969

    Google Scholar 

  • Furst DE. Clinical pharmacology of very low dose methotrexate for use in rheumatoid arthritis. Journal of Rheumatology 12 (Suppl. 12): 11–14, 1985

    PubMed  Google Scholar 

  • Gispen JG, Alarcon GS, Johnson JJ, Alton RT, et al. Toxicity to methotrexate in rheumatoid arthritis. Journal of Rheumatology 14: 74–79, 1987

    PubMed  CAS  Google Scholar 

  • Glick EN, Rigby P. Intra-articular use of triamcinolone hexacetonide. Arthritis and Rheumatism 14: 383–384, 1971

    Google Scholar 

  • Gray RG, Tenenbaum TJ, Gottlieb NL. Local corticosteroid injection treatment in rheumatic disorders. Seminars in Arthritis and Rheumatism 10: 231–254, 1981

    PubMed  CAS  Google Scholar 

  • Griffiths CEM, Powles AV, Leonard JN, Fry L, Baker BS, et al. Clearance of psoriasis with low dose cyclosporin. British Medical Journal 293: 731–732, 1986

    PubMed  CAS  Google Scholar 

  • Groff GD, Shenberger FN, Wilke WS, Taylor TM. Low dose oral methotrexate in rheumatoid arthritis: an uncontrolled trial and review of the literature. Seminars in Arthritis and Rheumatism 12: 333–347, 1983

    PubMed  CAS  Google Scholar 

  • Gubner R, August S, Ginsberg V. Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis. American Journal of the Medical Sciences 22: 176–182, 1951

    Google Scholar 

  • Hall ND, Bird HA, Ring EFJ, Bacon PA. A combined clinical and immunological assessment of four cyclophosphamide regimens in rheumatoid arthritis. Agents and Actions 9: 97–102, 1979

    PubMed  CAS  Google Scholar 

  • Hamdy H, McKendry RJR, Merins E, Liver JA. Low dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis: a 24-week controlled clinical trial. Arthritis and Rheumatism 30: 361–368, 1987

    PubMed  CAS  Google Scholar 

  • Hansen TM, Dickmeiss E, Jans H, Hansen TI, Ingeman-Nielsen M, et al. Combination of methylprednisolone pulse therapy and remission inducing drugs in rheumatoid arthritis. Annals of the Rheumatic Diseases 46: 290–295, 1987

    PubMed  CAS  Google Scholar 

  • Harris ED, Emkey RD, Nicholas JE, Newberg A. Low dose prednisolone therapy in rheumatoid arthritis: a double blind study. Journal of Rheumatology 10: 713–721, 1983

    PubMed  Google Scholar 

  • Hartmann FA, Brownell KA, Hartmann WE. A further study of the hormone of the adrenal cortex. American Journal of Physiology 95: 670–680, 1930

    Google Scholar 

  • Hatchuel R. Efficacité et mode d’action du Chlorambucil dans la polyarthrite rheumatoide. Étude controlée en double insu. À propos de 47 observations. Mémoire pour l’obtention du Certificat D’Études Speciales en Rheumatologie, Paris, 1972

  • Hench PS, Kendall EL, Slocumb CH, Polley HF. The effect of a hormone of the adrenal cortex (17-hydroxy-11 dehydroxycorticosterone; compound E), and of pituitary adrenocorticotropic hormone on rheumatoid arthritis: a preliminary report. Mayo Clinic Proceedings 24: 181–197, 1949

    CAS  Google Scholar 

  • Herrman B, Muller W. Die therapie der chronischen polyarthritis mit cyclosporin A, einen nuen immunosuppressivum. Aktuelle Rheumatologie 4: 173–186, 1979

    Google Scholar 

  • Hess EV, Kammen PL. Pulse therapy in rheumatoid arthritis. Annals of Internal Medicine 94: 128–129, 1981

    PubMed  CAS  Google Scholar 

  • Ho M, Wajszcuk A, Dummer JS, Starzl TE, Hakala TR. Infections in kidney, heart and liver transplant recipients on cyclosporin. Transplantation Proceedings 15: 2768–2774, 1983

    Google Scholar 

  • Hoffmeister R. Methotrexate in rheumatoid arthritis. Arthritis and Rheumatism 15: 114, 1972

    Google Scholar 

  • Hoffmeister RT. Methotrexate therapy in rheumatoid arthritis: 15 years experience. American Journal of Medicine 12: 69–73, 1983

    Google Scholar 

  • Huffman DH, Wan SH, Azarnoff DL, et al. Pharmacokinetics of methotrexate. Clinical Pharmacology and Therapeutics 14: 572–579, 1973

    PubMed  CAS  Google Scholar 

  • Ianuzzi L, Dawson N, Zein N, Kushner I. Does drug therapy slow radiographic progression in rheumatoid arthritis? New England Journal of Medicine 303: 1023–1028, 1983

    Google Scholar 

  • Isomaki J, Mutru O, Koota K. Death rate and causes of death in patients with rheumatoid arthritis. Scandinavian Journal of Rheumatology 4: 205–208, 1975

    PubMed  CAS  Google Scholar 

  • Jiminez-Diaz CJ, Garcia EL, Merchante A, Perianes J. Treatment of rheumatoid arthritis with nitrogen mustard: preliminary report. Journal of the American Medical Association 147: 1418–1419, 1951

    Google Scholar 

  • Johns DG, Rutherford LD, Leighton PG, Vogel CL. Secretion of methotrexate into human milk. American Journal of Obstetrics and Gynecology 112: 978–980, 1972

    PubMed  CAS  Google Scholar 

  • Johnson WW, Meadows DC. Urinary bladder fibrosis and telangiectasia associated with long term cyclophosphamide therapy. New England Journal of Medicine 284: 290–294, 1971

    PubMed  CAS  Google Scholar 

  • Kahan BD, Reid M, Newburger J. Pharmacokinetics of cyclosporin in human renal transplantation. Transplant Proceedings 15: 446–453, 1983

    Google Scholar 

  • Kahn MF, Arlet J, Bloch-Michel A, Canoit M, Chaovat Y, et al. 19 leucoses aigues après traitement des rhumatismes inflammatoires chronique et des connectivités par les agents cytolytiques à visée immunodepressive. Resultats d’une enquête rétrospective portant sur 2006 cas. Revue du Rhumatisme et des Maladies Ostéo-Articulaires 49: 163, 1979

    Google Scholar 

  • Kahn MF, Bedoiseau M, de Seze S. Immunosuppressive drugs in the management of malignant and severe rheumatoid arthritis. Proceedings of the Royal Society of Medicine 60: 130–133, 1967

    PubMed  CAS  Google Scholar 

  • Kahn MF, Bedoiseau M, Six B, Le Goff P, de Seze S. Chlorambucil in rheumatoid arthritis. Revue du Rhumatisme et des Maladies Ostéo-Articulaires 38: 741–748, 1971

    PubMed  CAS  Google Scholar 

  • Karvosky J. Clinical pharmacology and toxicology of cyclophosphamide: emphasis on use in rheumatic disease. Seminars in Arthritis and Rheumatism 12: 359–372, 1983

    Google Scholar 

  • Keown PA, Stiller CR, Laupacis AL, Howson W, Coles R, et al. The effects and side effects of cyclosporine: relationship to drug pharmacokinetics. Transplantation Proceedings 14: 36–45, 1982

    Google Scholar 

  • Kinlen LJ. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment. American Journal of Medicine 78 (Suppl. 1A): 44–49, 1985

    PubMed  CAS  Google Scholar 

  • Kremer JM, Galivan J, Strekfuss A, Kamen B. Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients: association with hepatic folic acid deficiency and formation of polyglutamates. Arthritis and Rheumatism 29: 832–835, 1986

    PubMed  CAS  Google Scholar 

  • Kremer JM, Lee JK. The safety and efficacy of the use of methotrexate in long term therapy for rheumatoid arthritis. Arthritis and Rheumatism 29: 822–831, 1986

    PubMed  CAS  Google Scholar 

  • Lebranchu Y, Drucker J, Nivet H, Rolland JC, Grenier B, et al. Acute monoblastic leukaemia in a child receiving chlorambucil for juvenile rheumatoid arthritis. Lancet 1: 649, 1980

    PubMed  CAS  Google Scholar 

  • Lee P, Anderson JA, Miller J, Webb J, Buchanan WW. Evaluation of analgesic action and efficacy of antirheumatic drug. Journal of Rheumatology 3: 283–294, 1976

    PubMed  CAS  Google Scholar 

  • Leibling MR, Lieb E, McLaughlin K, Blocka K, Furst D, et al. A double blind crossover trial of methyl prednisolone pulse therapy in rheumatoid arthritis. Arthritis and Rheumatism 23: 711, 1980

    Google Scholar 

  • Leibling MR, Lieb E, McLaughlin K, Blocka K, Furst DE, et al. Pulse methylprednisolone in rheumatoid arthritis: a double-blind crossover trial. Annals of Internal Medicine 94: 21–26, 1981

    Google Scholar 

  • Levy J, Paulus HE. Comparison of azathioprine and cyclophosphamide in the treatment of rheumatoid arthritis. Arthritis and Rheumatism 18: 412–413, 1975

    Google Scholar 

  • Levy J, Paulus HE, Bangert R. Comparison of azathioprine and cyclophosphamide in treatment of rheumatoid arthritis. Arthritis and Rheumatism 18: 412–417, 1975

    Google Scholar 

  • Levy J, Paulus HE, Barnett EV, et al. A double blind controlled evaluation of azathioprine treatment in rheumatoid arthritis and psoriatic arthritis. Arthritis and Rheumatism 15: 116–117, 1972

    Google Scholar 

  • Lewis GJ, Lamont CAR, Lee HA, Slapak M. Successful pregnancy in a renal transplant recipient taking cyclosporin A. British Medical Journal 286: 603, 1983

    PubMed  CAS  Google Scholar 

  • Lewis P, Hazleman BL, Hanka R, Roberts S. Cause of death in patients with rheumatoid arthritis treated with azathioprine. Annals of the Rheumatic Diseases 39: 457–461, 1980

    PubMed  CAS  Google Scholar 

  • Lidksy MD, Sharp JT, Billings S. Double blind study of cyclophophamide in rheumatoid arthritis. Arthritis and Rheumatism 16: 148–153, 1973

    Google Scholar 

  • Lockie ML, Gomez E, Smith DM. Low dose adrenocorticoids in the management of elderly patients with rheumatoid arthritis: selected examples and summary of efficacy in the long term treatment of 97 patients. Seminars in Arthritis and Rheumatism 12: 373–382, 1983

    PubMed  CAS  Google Scholar 

  • MacKenzie AH. Liver biopsy findings after methotrexate therapy for rheumatoid arthritis. Journal of Rheumatology 1 (Suppl. 1): 73, 1974

    Google Scholar 

  • MacKinnon S, Starkebaum G, Willkens RF. Pancytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis. Seminars in Arthritis and Rheumatism 15: 119–126, 1985

    PubMed  CAS  Google Scholar 

  • Madhok R, Capell H. Cyclosporin A: a potential disease modifying drug in rheumatoid arthritis. Arthritis and Rheumatism 28 (Suppl.): S68, 1985

    Google Scholar 

  • Mason M, Currey HLF, Barnes CG, Dunne JF, Hazleman BL, et al. Azathioprine in rheumatoid arthritis. British Medical Journal 1: 420–422, 1969

    PubMed  CAS  Google Scholar 

  • Medical Research Council and Nuffield Foundation on Clinical Trials. A comparison of cortisone and aspirin in the treatment of early cases of rheumatoid arthritis. British Medical Journal 1: 695–700, 1955

    Google Scholar 

  • Meffin PJ, Brooks PM, Sallustio BC. Alterations in prednisolone disposition as a result of time of administration, gender and dose. British Journal of Clinical Pharmacology 17: 395–404, 1984

    PubMed  CAS  Google Scholar 

  • Miller III JJ, Williams GF, Leissring JG. Multiple late complications of cyclophosphamide, including ovarian destruction. American Journal of Medicine 50: 530–535, 1971

    PubMed  Google Scholar 

  • Millon R, Kellgren JH, Poole P, Jayson MIV. Long term study of management of rheumatoid arthritis. Lancet 1: 812–816, 1984

    Google Scholar 

  • Mitchell DM, Spitz PW, Young DY, Bloch DA, McShane DJ, et al. Survival, prognosis and causes of death in rheumatoid arthritis. Arthritis and Rheumatism 29: 706–714, 1986

    PubMed  CAS  Google Scholar 

  • Müftüglu AU, Pazarli H, Yurdakul S, Yazici H, Ülkü BY, et al. Short term cyclosporin A treatment of Bechet’s disease. British Journal of Ophthalmology 71: 387–390, 1987

    Google Scholar 

  • Myles AB, Daly JR. Effect of corticosteroids and adrenocorticotrophic hormone on the hypothalamo-pituitary-adrenal axis. In Corticosteroid and ACTH treatment, pp. 66–81, Arnold, London, 1974

  • Myles A. Corticosteroid treatment in rheumatoid arthritis. British Journal of Rheumatology 24: 125–127, 1985

    PubMed  CAS  Google Scholar 

  • Needs CJ, Smith M, Boutagy J, Donovan S, Cosh D, et al. Comparison of methylprednisolone (1 gram IV) with prednisolone (1 gram orally) in rheumatoid arthritis: a pharmacokinetic and clinical study. Journal of Rheumatology 15: 224–228, 1988

    PubMed  CAS  Google Scholar 

  • Neumann VC, Hopkins R, Dixon JS, Bird HA, Wright VA. Combination therapy with pulsed methylprednisolone in rheumatoid arthritis: alone or in combination. British Journal of Rheumatology 23: 118–119, 1984

    Google Scholar 

  • Nolan GH, Sweet RL, Laros RF, Roure CA. Renal cadaver transplantation followed by successful pregnancies. Obstetrics and Gynecology 43: 732–739, 1974

    PubMed  CAS  Google Scholar 

  • Nordstrom DM, West SG, Anderson PA. Pulse methotrexate in rheumatoid arthritis: a controlled prospective roentenographic study. Annals of Internal Medicine 107: 797–801, 1987

    PubMed  CAS  Google Scholar 

  • Nussenblatt RB, Palestine AG, Chan CC, Mochizuki M, Yancey K. Effectiveness of cyclosporin therapy for Bechet’s disease. Arthritis and Rheumatism 28: 671–679, 1985

    PubMed  CAS  Google Scholar 

  • O’Callaghan JW, Brooks PM. Disease modifying agents and immunosuppressive drugs in the elderly. Clinics in Rheumatoid Diseases 12: 275–289, 1986

    Google Scholar 

  • Palestine AG, Nussenblatt RB, Chan CC. Side effects of systemic cyclosporin in patients not undergoing transplantation. American Journal of Medicine 77: 652–656, 1984

    PubMed  CAS  Google Scholar 

  • Palmer RG, Varonos S, Dore CJ, Denman AM, Ansell BM. Chlorambucil induced chromosome damage in juvenile chronic arthritis. Archives of Disease in Childhood 60: 1008–1013, 1985

    PubMed  CAS  Google Scholar 

  • Paulus HE, Williams JH, Ward JR, Reading JC, Egger MJ, et al. Azathioprine versus d-penicillamine in rheumatoid arthritis patients who have been treated unsuccessfully with gold. Arthritis and Rheumatism 27: 721–727, 1984

    PubMed  CAS  Google Scholar 

  • Pickup ME. Clinical pharmacokinetics of prednisone and prednisolone. Clinical Pharmacokinetics 4: 111–128, 1979

    PubMed  CAS  Google Scholar 

  • Rasker JJ, Cosh JA. Cause and age at death in a prospective study of 100 patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 40: 115–120, 1981

    PubMed  CAS  Google Scholar 

  • Reese LT, Grimsham JW, Aach RD, Eisen AZ. Effects of methotrexate on the liver in psoriasis. Journal of Investigative Dermatology 62: 597–602, 1974

    PubMed  CAS  Google Scholar 

  • Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Quarterly Journal of Medicine 37: 393–406, 1968

    PubMed  CAS  Google Scholar 

  • Sambrook PN, Eisman JA, Yeates MG, Pocock NA, Ebert S, et al. Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids. Annals of the Rheumatic Diseases 45: 950–953, 1986

    PubMed  CAS  Google Scholar 

  • Scherbel AL. Intravenous administration of nitrogen mustard alone and with corticotropin for rheumatoid arthritis. Cleveland Clinic Quarterly 24: 75–82, 1957

    Google Scholar 

  • Schilsky RL, Lewis BJ, Sherins RJ, Young RC. Gonadal dysfunction in patients receiving chemotherapy for cancer. Annals of Internal Medicine 93: 109–114, 1980

    PubMed  CAS  Google Scholar 

  • Scott DGI, Bacon PA. Intravenous cyclophosphamide plus methylprednisolone in the treatment of systemic rheumatoid vasculitis. American Journal of Medicine 76: 77–85, 1984

    Google Scholar 

  • Scott DL, Symmonds DPM, Coulton BL. Long term outcome of treating rheumatoid arthritis: results after 20 years. Lancet 1: 1108–1111, 1987

    PubMed  CAS  Google Scholar 

  • Settas L, Alexiou P, Mataftsi E, et al. Oral methotrexate in rheumatoid arthritis: a double blind crossover study. Clinical and Experimental Rheumatology 5 (Suppl. 2): 122, 1987

    Google Scholar 

  • Skolal JE, Lessman EM. Effects of cancer chemotherapy on the human fetus. Journal of the American Medical Association 172: 1765–1767, 1960

    Google Scholar 

  • Smyth CJ, Bartholomew BA, Mills DM, Steigerwald JC, Strong SJ, et al. Cyclophosphamide therapy for rheumatoid arthritis. Archives of Internal Medicine 135: 789–793, 1975

    PubMed  CAS  Google Scholar 

  • Sostman HD, Matthay RA, Putman CE. Methotrexate induced pneumonitis. Medicine 55: 371–388, 1976

    PubMed  CAS  Google Scholar 

  • St Clair EW, Ric JR, Snyderman R. Pneumonitis complicating low dose methotrexate therapy in rheumatoid arthritis. Archives of Internal Medicine 145: 2035–2038, 1985

    Google Scholar 

  • Starzl TE, Nalesnick MA, Porter KA, Ho M, Iwatsuki S, et al. Reversibility of lymphoma and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1: 583–587, 1984

    PubMed  CAS  Google Scholar 

  • Swingle WW, Pfiffner JJ. Experiments with an active extract of the suprarenal cortex. Anatomical Record 44: 225–226, 1930a

    Google Scholar 

  • Swingle WW, Pfiffner JJ. An aqueous extract of the suprarenal cortex which maintains the life of bilaterally adrenalectomised cats. Science 71: 321–322, 1930b

    PubMed  CAS  Google Scholar 

  • Tannenbaum H, Schur PH. Development of reticulum cell sarcoma during cyclophosphamide therapy. Arthritis and Rheumatism 17: 15–17, 1974

    PubMed  CAS  Google Scholar 

  • Thompson RN, Watts C, Edelman J, Esdaile J, Russel AS. A controlled two centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis. Journal of Rheumatology 11: 760–763, 1984

    PubMed  CAS  Google Scholar 

  • Thorpe P, Hassal JE, York JR. Rheumatoid arthritis treated with chlorambucil: a five year follow up. Medical Journal of Australia 2: 197–199, 1976

    PubMed  CAS  Google Scholar 

  • Tolman KG, Clegg DO, Lee RG, Ward JR. Methotrexate and the liver. Journal of Rheumatology 12 (Suppl. 12): 29–34, 1985

    PubMed  Google Scholar 

  • Townes AJ, Sowa JM, Shulman LE. Controlled trial of cyclophosphamide in rheumatoid arthritis. Arthritis and Rheumatism 19: 563–573, 1976

    PubMed  CAS  Google Scholar 

  • Tugwell P, Bennett K, Gent M. Methotrexate in rheumatoid arthritis: indications, contraindications, efficacy and safety. Annals of Internal Medicine 107: 358–366, 1987

    PubMed  CAS  Google Scholar 

  • Uddin J, Kraus AS, Kelly HG. Survivorship and death in rheumatoid arthritis. Arthritis and Rheumatism 13: 125–131, 1970

    PubMed  CAS  Google Scholar 

  • Urowitz MB, Gordon DA, Smythe HA, Prozanski W, Oeryzlo MA. Azathioprine in rheumatoid arthritis: a double-blind, crossover study. Arthritis and Rheumatism 16: 411–417, 1973

    PubMed  CAS  Google Scholar 

  • Urowitz MB, Hunter T, Bookman AAM, Gordon DA, Smythe HA, et al. Azathioprine in rheumatoid arthritis: a double blind study comparing full dose to half dose. Journal of Rheumatology 1: 274–281, 1974

    Google Scholar 

  • Urowitz MB, Smythe HA, Able T, Norman CS, Travis C. Long term effects of azathioprine in rheumatoid arthritis. Annals of the Rheumatic Diseases 41 (Suppl.): 18–22, 1982

    PubMed  Google Scholar 

  • Van Rijthoven AWAM, Dijkmans BAC, Goei The HS, Hermans J, Montanor-Beckers ZLMB, et al. Cyclosporin treatment for rheumatoid arthritis: a placebo controlled, double blind, multi-centre study. Annals of the Rheumatic Diseases 45: 726–731, 1986

    PubMed  Google Scholar 

  • Vandermeer S, Imhoff JW, Borleffs JCC. Cyclosporin for polymyositis. Annals of the Rheumatic Diseases 45: 612, 1986

    CAS  Google Scholar 

  • Warne GL, Fairley KF, Hobbs JB, Martin FIR. Cyclophosphamide induced ovarian failure. New England Journal of Medicine 289: 1159–1162, 1973

    PubMed  CAS  Google Scholar 

  • Weinblatt ME. Toxicity of low dose methotrexate in rheumatoid arthritis. Journal of Rheumatology 12 (Suppl. 12): 35–39, 1985

    PubMed  Google Scholar 

  • Weinblatt ME, Coblyn JS, Fox DA, Fraser PA, Holdsworth DE, et al. Efficacy of low dose methotrexate in rheumatoid arthritis. New England Journal of Medicine 312: 818–822, 1985

    PubMed  CAS  Google Scholar 

  • Weinblatt ME, Coblyn JS, Fraser PA, Anderson RJ, Spragg J, et al. Cyclosporin A treatment of refractory rheumatoid arthritis. Arthritis and Rheumatism 30: 11–17, 1987

    PubMed  CAS  Google Scholar 

  • Weinstein A, Bujac D. Methotrexate or gold in early rheumatoid arthritis: a double blind study. Clinical and Experimental Rheumatology (Suppl. 2): 122, 1987

    Google Scholar 

  • Weiss RB, Muggia FM. Cytotoxic drug-induced pulmonary disease. American Journal of Medicine 68: 259–266, 1980

    PubMed  CAS  Google Scholar 

  • Williams HJ, Willkens RF, Samuelson CO, Alarcon GS, Guttadauria M, et al. Comparison of low dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis: a controlled clinical trial. Arthritis and Rheumatism 28: 721–730, 1985

    PubMed  CAS  Google Scholar 

  • Williams IA, Bayliss EM, Shipley ME. A double blind placebo controlled trial of methyl prednisolone pulse therapy in active rheumatoid disease. Lancet 2: 2137–2140, 1982

    Google Scholar 

  • Williams JH, Reading JC, Ward JR, O’Brien WM. Comparison of high and low dose cyclophosphamide therapy in rheumatoid arthritis. Arthritis and Rheumatism 23: 521–527, 1980

    PubMed  CAS  Google Scholar 

  • Willkens RF, Watson MA, Paxson CS. Low dose pulse methotrexate therapy in rheumatoid arthritis. Journal of Rheumatology 7: 501–505, 1980

    PubMed  CAS  Google Scholar 

  • Wood AJ, Maurer G, Niederberger W, Beveridge T. Cyclosporine: pharmacokinetics, metabolism and drug interactions. Transplantation Proceedings 15: 2409–2415, 1983

    CAS  Google Scholar 

  • Woodland J, Chaput de Saintonge DM, Evans SJW, Sharman VL, Currey HLF. Azathioprine in rheumatoid arthritis: a double blind study of full versus half doses versus placebo. Annals of the Rheumatic Diseases 40: 355–359, 1981

    PubMed  CAS  Google Scholar 

  • Zachariae H, Grunnet E, Sogaard H. Liver biopsy in methotrexate treated psoriatics: a re-evaluation. Acta Dermato-Venereologica (Stockholm) 55: 291–296, 1975

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arnold, M., Schrieber, L. & Brooks, P. Immunosuppressive Drugs and Corticosteroids in the Treatment of Rheumatoid Arthritis. Drugs 36, 340–363 (1988). https://doi.org/10.2165/00003495-198836030-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198836030-00005

Keywords

Navigation